Cancer Cachexia Global Market Report 2025

Description

Cancer cachexia is a complex metabolic syndrome characterized by progressive weight loss, muscle wasting, weakness, fatigue, and loss of appetite in individuals with cancer. This multifactorial condition arises from a combination of factors, including inflammation, metabolic abnormalities, and the presence of tumors. Cancer cachexia can significantly impact a patient's quality of life, impair their ability to tolerate cancer treatments, and reduce overall survival.

The main therapeutics for cancer cachexia include progestogens, corticosteroids, combination therapies, and others. Progestogens, a type of medication often used in treating cancer cachexia, work by mimicking the effects of natural progesterone hormones in the body, potentially helping to increase appetite and muscle mass in patients. These treatments operate through various mechanisms, such as appetite stimulation and weight loss stabilization, and are distributed via hospital stores, retail pharmacies, and online pharmacies.

The cancer cachexia market research report is one of a series of new reports from The Business Research Company that provides cancer cachexia market statistics, including cancer cachexia industry global market size, regional shares, competitors with a cancer cachexia market share, detailed cancer cachexia market segments, market trends and opportunities, and any further data you may need to thrive in the cancer cachexia industry. This cancer cachexia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer cachexia market size has grown strongly in recent years. It will grow from $2.47 billion in 2024 to $2.62 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to an improved understanding of cancer biology, the prevalence of cancer, an increased aging population, a greater focus on patient-centered care, expanding treatment options, and growing awareness among healthcare providers.

The cancer cachexia market size is expected to see strong growth in the next few years. It will grow to $3.33 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rising awareness about cachexia management, expanding geriatric population, growing adoption of novel therapeutic approaches, rising healthcare expenditure, and favorable government initiatives. Major trends in the forecast period include increasing research and development efforts, expanding therapeutic options, improved diagnosis rates, adoption of novel treatment modalities, and advancements in supportive care strategies.

The growing prevalence of cancer is expected to drive the expansion of the cancer cachexia market. Cancer is a condition characterized by the uncontrolled proliferation of abnormal cells, leading to tumor formation and disruption of normal bodily functions. The increasing incidence of cancer is attributed to several factors, including lifestyle changes, environmental influences, aging populations, genetic predisposition, improved diagnostic techniques allowing for earlier detection, and greater public awareness, leading more individuals to seek medical attention. Advances in medical technology and a deeper understanding of cancer and its associated complications are contributing to more frequent diagnoses and reporting of cancer cachexia. Healthcare providers are becoming more adept at identifying the symptoms of cachexia, enabling earlier treatment interventions. For example, in December 2023, the Australian Bureau of Statistics reported that approximately 1.8% of the Australian population, or 456,200 individuals, were diagnosed with cancer in 2022. Additionally, the National Cancer Institute, a US-based federal agency, projected that 2,001,140 new cancer cases would be diagnosed in the U.S. in 2024, with 611,720 expected deaths. In 2022, there were nearly 20 million new cases and 9.7 million cancer-related deaths globally. By 2040, the number of new cancer cases is expected to reach 29.9 million annually, with cancer-related deaths rising to 15.3 million. Thus, the increasing prevalence of cancer is significantly driving the growth of the cancer cachexia market.

Key players in the cancer cachexia market are focusing on developing innovative treatments, such as monoclonal antibodies, to provide targeted solutions for managing cancer cachexia and improving patients' body weight, muscle mass, and overall quality of life. Monoclonal antibodies for cachexia work by targeting and inhibiting the factors responsible for muscle and weight loss. For example, in September 2024, Pfizer Inc., a US-based pharmaceutical company, reported the positive results from its Phase 2 trial of Ponsegromab, a monoclonal antibody aimed at targeting GDF-15 in cancer cachexia patients. The study showed a significant increase in body weight, along with improvements in muscle mass, appetite, and physical activity, with the 400 mg dose yielding the most notable results. Following these encouraging outcomes, Pfizer plans to launch registration-enabling studies in 2025 to further explore Ponsegromab's potential as a treatment for cancer cachexia.

In January 2023, LG Chem Ltd., a South Korean chemical company, acquired AVEO Oncology for an undisclosed amount. This acquisition aims to diversify LG Chem's product portfolio and enhance its capabilities in drug development, commercialization, and acquisitions, thereby accelerating its progress toward delivering cutting-edge cancer treatments. AVEO Oncology, a US-based biopharmaceutical company, provides a potential treatment for cancer cachexia.

Major companies operating in the cancer cachexia market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Novartis International AG, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Kyowa Kirin Co. Ltd., Hikma Pharmaceuticals plc, Endo International plc, Aspen Pharmacare Holdings Limited, Lupin Limited, Mallinckrodt plc, Akorn Inc., Aeterna Zentaris, XBiotech Inc.

North America was the largest region in the cancer cachexia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer cachexia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer cachexia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer cachexia market consists of revenues earned by entities by providing services such as nutritional counseling, physical therapy, and exercise training. The market value includes the value of related goods sold by the service provider or included within the service offering. The cancer cachexia market also includes sales of anabolic steroids, nonsteroidal anti-inflammatory drugs (NSAIDs), and oral nutritional supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Cachexia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer cachexia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer cachexia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer cachexia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Therapeutics: Progestogens; Corticosteroids; Combination Therapies; Other Therapeutics
2) By Mechanism Of Action: Appetite Stimulators; Weight Loss Stabilizers; Other Mechanisms Of Actions
3) By Distribution Channel: Hospital Stores; Retail Pharmacy Stores; Online Pharmacies
Subsegments:
1) By Progestogens: Megestrol Acetate; Medroxyprogesterone Acetate; Hydroxyprogesterone Caproate
2) By Corticosteroids: Dexamethasone; Prednisolone; Methylprednisolone
3) By Combination Therapies: Progestogens + Corticosteroids; Progestogens + Anabolic Agents; Corticosteroids + Anabolic Agents
4) By Other Therapeutics: Anabolic Agents; Appetite Stimulants; Anti-inflammatory Drugs; Nutritional Supplements
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r29689

1. Executive Summary

2. Cancer Cachexia Market Characteristics

3. Cancer Cachexia Market Trends And Strategies

4. Cancer Cachexia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cancer Cachexia Growth Analysis And Strategic Analysis Framework

5.1. Global Cancer Cachexia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cancer Cachexia Market Growth Rate Analysis
5.4. Global Cancer Cachexia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cancer Cachexia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cancer Cachexia Total Addressable Market (TAM)

6. Cancer Cachexia Market Segmentation

6.1. Global Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Progestogens
Corticosteroids
Combination Therapies
Other Therapeutics
6.2. Global Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Appetite Stimulators
Weight Loss Stabilizers
Other Mechanisms Of Actions
6.3. Global Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Stores
Retail Pharmacy Stores
Online Pharmacies
6.4. Global Cancer Cachexia Market, Sub-Segmentation Of Progestogens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Megestrol Acetate
Medroxyprogesterone Acetate
Hydroxyprogesterone Caproate
6.5. Global Cancer Cachexia Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dexamethasone
Prednisolone
Methylprednisolone
6.6. Global Cancer Cachexia Market, Sub-Segmentation Of Combination Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Progestogens + Corticosteroids
Progestogens + Anabolic Agents
Corticosteroids + Anabolic Agents
6.7. Global Cancer Cachexia Market, Sub-Segmentation Of Other Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anabolic Agents
Appetite Stimulants
Anti-inflammatory Drugs
Nutritional Supplements

7. Cancer Cachexia Market Regional And Country Analysis

7.1. Global Cancer Cachexia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cancer Cachexia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Cachexia Market

8.1. Asia-Pacific Cancer Cachexia Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Cachexia Market

9.1. China Cancer Cachexia Market Overview
9.2. China Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Cachexia Market

10.1. India Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Cachexia Market

11.1. Japan Cancer Cachexia Market Overview
11.2. Japan Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Cachexia Market

12.1. Australia Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Cachexia Market

13.1. Indonesia Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Cachexia Market

14.1. South Korea Cancer Cachexia Market Overview
14.2. South Korea Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Cachexia Market

15.1. Western Europe Cancer Cachexia Market Overview
15.2. Western Europe Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Cachexia Market

16.1. UK Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Cachexia Market

17.1. Germany Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Cachexia Market

18.1. France Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Cachexia Market

19.1. Italy Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Cachexia Market

20.1. Spain Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Cachexia Market

21.1. Eastern Europe Cancer Cachexia Market Overview
21.2. Eastern Europe Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Cachexia Market

22.1. Russia Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Cachexia Market

23.1. North America Cancer Cachexia Market Overview
23.2. North America Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Cachexia Market

24.1. USA Cancer Cachexia Market Overview
24.2. USA Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Cachexia Market

25.1. Canada Cancer Cachexia Market Overview
25.2. Canada Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Cachexia Market

26.1. South America Cancer Cachexia Market Overview
26.2. South America Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Cachexia Market

27.1. Brazil Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Cachexia Market

28.1. Middle East Cancer Cachexia Market Overview
28.2. Middle East Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Cachexia Market

29.1. Africa Cancer Cachexia Market Overview
29.2. Africa Cancer Cachexia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cancer Cachexia Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cancer Cachexia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Cachexia Market Competitive Landscape And Company Profiles

30.1. Cancer Cachexia Market Competitive Landscape
30.2. Cancer Cachexia Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Cachexia Market Other Major And Innovative Companies

31.1. Bristol Myers Squibb Company
31.2. AstraZeneca plc
31.3. Novartis International AG
31.4. Fresenius SE & Co. KGaA
31.5. GlaxoSmithKline plc
31.6. Takeda Pharmaceutical Company
31.7. Eli Lilly and Company
31.8. Boehringer Ingelheim International GmbH
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Astellas Pharma Inc.
31.11. Daiichi Sankyo Company Limited
31.12. Sun Pharmaceutical Industries Ltd.
31.13. Perrigo Company plc
31.14. Kyowa Kirin Co. Ltd.
31.15. Hikma Pharmaceuticals plc

32. Global Cancer Cachexia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Cachexia Market

34. Recent Developments In The Cancer Cachexia Market

35. Cancer Cachexia Market High Potential Countries, Segments and Strategies

35.1 Cancer Cachexia Market In 2029 - Countries Offering Most New Opportunities
35.2 Cancer Cachexia Market In 2029 - Segments Offering Most New Opportunities
35.3 Cancer Cachexia Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer